These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 3002245
1. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir. McLaren C, Chen MS, Ghazzouli I, Saral R, Burns WH. Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245 [Abstract] [Full Text] [Related]
2. A mammalian cell line designed to test the mutagenic activity of anti-herpes nucleosides. Pizer LI, Mitchell DH, Bentele B, Betz JL. Int J Cancer; 1987 Jul 15; 40(1):114-21. PubMed ID: 3036717 [Abstract] [Full Text] [Related]
3. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Ellis MN, Keller PM, Fyfe JA, Martin JL, Rooney JF, Straus SE, Lehrman SN, Barry DW. Antimicrob Agents Chemother; 1987 Jul 15; 31(7):1117-25. PubMed ID: 2821890 [Abstract] [Full Text] [Related]
4. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Coen DM, Irmiere AF, Jacobson JG, Kerns KM. Virology; 1989 Feb 15; 168(2):221-31. PubMed ID: 2536980 [Abstract] [Full Text] [Related]
5. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir. Field HJ, Neden J. Antiviral Res; 1982 Oct 15; 2(5):243-54. PubMed ID: 6295272 [Abstract] [Full Text] [Related]
6. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. Nugier F, Colin JN, Aymard M, Langlois M. J Med Virol; 1992 Jan 15; 36(1):1-12. PubMed ID: 1315366 [Abstract] [Full Text] [Related]
7. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2. Schinazi RF, Fox JJ, Watanabe KA, Nahmias AJ. Antimicrob Agents Chemother; 1986 Jan 15; 29(1):77-84. PubMed ID: 3015003 [Abstract] [Full Text] [Related]
8. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient. Christophers J, Sutton RN. J Antimicrob Chemother; 1987 Sep 15; 20(3):389-98. PubMed ID: 2824424 [Abstract] [Full Text] [Related]
9. Herpes simplex virus resistance to antiviral drugs. Morfin F, Thouvenot D. J Clin Virol; 2003 Jan 15; 26(1):29-37. PubMed ID: 12589832 [Abstract] [Full Text] [Related]
10. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. Balzarini J, Bohman C, De Clercq E. J Biol Chem; 1993 Mar 25; 268(9):6332-7. PubMed ID: 8384209 [Abstract] [Full Text] [Related]
11. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. Collins P, Ellis MN. J Med Virol; 1993 Mar 25; Suppl 1():58-66. PubMed ID: 8245894 [Abstract] [Full Text] [Related]
12. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus. Shimada Y, Suzuki M, Shirasaki F, Saito E, Sogo K, Hasegawa M, Takehara K, Phromjai J, Chuhjo T, Shiraki K. J Med Virol; 2007 Nov 25; 79(11):1731-40. PubMed ID: 17854045 [Abstract] [Full Text] [Related]
13. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? Andrei G, De Clercq E, Snoeck R. Antiviral Res; 2004 Mar 25; 61(3):181-7. PubMed ID: 15168799 [Abstract] [Full Text] [Related]
14. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. Bestman-Smith J, Schmit I, Papadopoulou B, Boivin G. J Virol; 2001 Apr 25; 75(7):3105-10. PubMed ID: 11238837 [Abstract] [Full Text] [Related]
15. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice. Sakuma S, Yamamoto M, Kumano Y, Mori R. Arch Virol; 1988 Apr 25; 101(3-4):169-82. PubMed ID: 2845890 [Abstract] [Full Text] [Related]
16. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir. Field HJ, Lay E. Antiviral Res; 1984 Apr 25; 4(1-2):43-52. PubMed ID: 6331304 [Abstract] [Full Text] [Related]
17. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes. Schubert A, Gentner E, Bohn K, Schwarz M, Mertens T, Sauerbrei A. Antiviral Res; 2014 Jul 25; 107():16-22. PubMed ID: 24747042 [Abstract] [Full Text] [Related]
18. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy. Sibrack CD, McLaren C, Barry DW. Am J Med; 1982 Jul 20; 73(1A):372-5. PubMed ID: 6285725 [Abstract] [Full Text] [Related]
19. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan. Hasegawa T, Kawana T, Okuda T, Horii M, Tsukada T, Shiraki K. J Med Virol; 2001 Jan 20; 63(1):57-63. PubMed ID: 11130888 [Abstract] [Full Text] [Related]
20. Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides. Smee DF, Campbell NL, Matthews TR. Antiviral Res; 1985 Oct 20; 5(5):259-67. PubMed ID: 2998275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]